Recap: AbCellera Biologics Q1 Earnings

AbCellera Biologics ABCL reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

AbCellera Biologics beat estimated earnings by 63.64%, reporting an EPS of $0.54 versus an estimate of $0.33.

Revenue was up $113.84 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 5.68% increase in the share price the next day.

To track all earnings releases for AbCellera Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.